McDermott is proudly sponsoring the 2021 Cross-Border M&A and Private Equity Virtual Conference (MUMAC) which will be held virtually, streamed live from the Bayerischer Hof in Munich.
Sessions will include:
- Keynote...more
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
McDermott Will & Emery is delighted to welcome you to a panel discussion on “Private Equity in Healthcare” and a social reception held in conjunction with the SuperReturn International Conference 2020.
Our speakers will...more
2/11/2020
/ Events ,
Foreign Investment ,
Health Care Providers ,
Hospitals ,
Investment Funds ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Physicians ,
Private Equity
Cross Border M&A: The Impact of Brexit, the Trump Administration, and China’s Crackdown on Capital Flight
The combination of Brexit, the Trump Administration, and China’s tightening grasp on capital, appear to have created...more
12/6/2017
/ Acquisitions ,
Bilateral Investment Treaties ,
Capital Markets ,
China ,
Cross-Border Transactions ,
Department of Justice (DOJ) ,
Dispute Resolution ,
EU Data Protection Laws ,
Federal Trade Commission (FTC) ,
Foreign Acquisitions ,
Foreign Investment ,
Health Care Providers ,
Insolvency ,
Mergers ,
NAFTA ,
Trump Administration ,
UK Brexit ,
UK Insolvency Act